ESMO Congress 2024
Ergomed Group looks forward to attending ESMO Congress 2024 in Barcelona, Spain between 13-17 September, 2024.
The ESMO Congress is a globally influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.
If you’re attending, be sure to stop by Ergomed’s Booth #657. Our expert team will be available to answer any questions you may have and discuss how Ergomed’s tailored oncology solutions, with a specialization in Head & Neck cancers, can provide optimal support for your clinical trials.
Meet our Team at #ESMO24!
Ergomed Vice President of Global Medical Affairs, Dusan Markovic, has co-authored an abstract titled: “Prognostic significance of diagnostic staging in treatment naïve, resectable locally advanced primary oral cavity squamous cell carcinoma for neoadjuvant Leukocyte Interleukin Injection immunotherapy.” This important study explores the potential of neoadjuvant immunotherapy in improving treatment outcomes for patients with advanced oral cavity squamous cell carcinoma. Make sure to attend the relevant sessions at the ESMO Congress to learn more about this breakthrough research and its implications for oncology treatment.
We look forward to seeing you.
To maximize your visit, we encourage you to schedule a meeting with our oncology experts to discuss how Ergomed can support your clinical trials. Whether you need assistance with trial design, patient recruitment strategies, or regulatory compliance, our team is here to help you achieve success in your clinical research, particularly in the challenging field of oncology.
Setup a Meeting
"*" indicates required fields